We urge Congress to capitalize on the expertise of the community health centers as part of the EHE initiative so that we can expand PrEP and PrEP-related services by increasing funding from the current $102 million to $152 million, as proposed by President Biden’s FY2022 budget.
The HIV+Hepatitis Policy Institute strongly supports The PBM Accountability Study Act (HR 1829), which would require the Government Accountability Office to provide a comprehensive report to Congress on the ways in which PBMs influence the pricing of pharmaceuticals, impede competition, use rebates and also provide recommendations on ways to lower prescription drug costs.
On behalf of the HIV+Hepatitis Policy Institute, we respectfully submit this testimony in support of increased funding for domestic HIV and hepatitis programs in the FY 2021 Labor, HHS spending bill…
The HIV+Hepatitis Policy Institute appreciates the work the Senate has been doing over the last several months responding to the COVID-19 pandemic. We thank you for your continued attention to this crisis, particularly as it affects our nation’s public health infrastructure. We are very appreciative…
On behalf of the HIV+HEP Policy Institute, we respectfully submit this testimony in support of increased funding for domestic HIV and hepatitis programs in the FY 2021 Labor, HHS spending bill…